Hosted by: Mike Newshel and Suzie Yoon, Evercore ISI

October 30, 2019: 12:00 – 2:00pm

Healthcare has been slow to incorporate technology into the clinical continuum. An increasingly complex regulatory environment, misaligned incentives across key industry participants, mixed early attempts on basic health/well-being, and harnessing ‘Big Data’ in a population setting have stymied progress. Fortunately, a new wave of highly innovative companies has sprung up with the aim of merging technology with evidence-based medicine, offering the potential to finally fulfill the promise of enhancing patient care and revolutionizing the treatment paradigm for major disease conditions.

Mike Newshel and Suzie Yoon, healthcare equity analysts at Evercore ISI, will offer a series of panels aimed at demystifying this new class of technology-driven disruptors. Content will appeal to a broad audience, including payers, pharma/device partners, benefit managers, growth investors, and industry technologists.

Topics covered / panelists participating include:

• Going Beyond Behavioral Health to New Modalities
  • Cognoa
  • Pear Therapeutics
  • Akili Interactive
  • Livongo
  • Feel (Sentio Solutions)
  • Mymee
  • Biobeat
• Reimbursement Challenges + Potential for Digital Overload with Emerging DTx
  • Cognoa
  • Ipsos
  • MedRythms
  • Voluntis
  • AppliedVR
  • JOGO Health
• Opportunities for Partnership Across the Digital Therapy Continuum
  • Omada
  • Medstack
  • Welldoc
  • Biobeat
• The Influence of AI + Big Data Disruption
  • Omada Health
  • Dthera Sciences
  • The Learning Corp
  • Floreo
  • Cedar Gate Technologies

Panel participants represent a wide spectrum of the emerging industry and will be announced in the months leading up to HLTH 2019.